查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
癌症登记软体的全球市场:现状分析与预测(2022年～2028年)
市场调查报告书
商品编码
1241386

癌症登记软体的全球市场:现状分析与预测(2022年～2028年)

Cancer Registry Software Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 163 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球癌症登记软体的市场规模，在预测期间内(2022年～2028年)预计以约10.5％的年复合成长率成长。市场成长的主要促进因素之一，是在全球的癌症发生率增加。

本报告提供全球癌症登记软体市场相关调查分析，市场动态，趋势与机会，企业简介等资讯。

目录

第1章 市场简介

第2章 调查手法、前提条件

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19对登记软体市场的影响

第6章 癌症登记软体市场收益(2020年～2028年)

第7章 市场考察:各类型

  • 独立
  • 整合

第8章 市场考察:各部署

  • 云端
  • 内部部署

第9章 市场考察:各功能性

  • 癌症的报告
  • 患者的照护
  • 医学研究
  • 其他

第10章 市场考察:各终端用户

  • 政府
  • 民营企业
  • 医院
  • 生物科技製药企业
  • 其他

第11章 市场考察:各地区

  • 北美
    • 美国
    • 加拿大
    • 其他的北美
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他的亚太地区
  • 其他地区

第12章 癌症登记软体的市场动态

  • 推动市场要素
  • 市场课题
  • 影响的分析

第13章 癌症登记软体市场机会

第14章 癌症登记软体市场趋势

第15章 需求端和供应端的分析

  • 需求端分析
  • 供应端分析

第16章 价值链分析

第17章 竞争模式

  • 竞争情形
    • 波特的五力分析

第18章 企业简介

  • Rocky Mountain Cancer Centers
  • MCKESSON CORPORATION
  • Netdox Health Pvt. Ltd.
  • Elekta
  • IBM
  • C-Net Solutions
  • Ordinal Data, Inc
  • Omega Healthcare
  • Energy & Resource Solutions
  • Conduent, Inc.

第19章 免责声明

简介目录
Product Code: UMME211703

The Cancer Registry Software Market is expected to witness a CAGR of around 10.5% during the forecast period i.e., 2022-2028. Cancer registry software is a database or information system that helps collect information about cancer patients. One of the key factors driving the growth of the global cancer registry software market is the increasing incidence of cancer across the globe. For instance, according to the California Institute for Regenerative Medicine (CIRM) prostate cancer is the second leading cause of cancer death among men in the U.S., with a 60% occurrence rate in men over the age of 65. Approximately 61,860 patients are expected to die from prostate cancer in California in the year 2021. Cancer registry software helps track and monitor the health status of patients suffering from cancer. Data collected using cancer registry software helps researchers and doctors develop therapies to treat cancer. Therefore, the global cancer registry software market is expected to grow in the coming years.

In addition, the rising geriatric population is also boosting the growth of the cancer registry software market during the forecast period. Data collected by cancer registry software helps stop the spread of cancer around the world. The software also helps governments track patients in specific locations and regions. As a result, this factor is supporting the growth of the global cancer registry software market.

Based on type, the market is segmented into standalone and integration. The standalone segment is expected to grow significantly during the forecast period. Standalone cancer registry software integrated with the latest and most advanced features. It is also easy to use and operate. Standalone cancer registry software also helps reduce overhead. Therefore, all these factors are driving the growth of the segment.

On the basis of deployment, the market is bifurcated into on-premises and cloud. The on-premise segment dominated the cancer registry software market in 2020. On-premise cancer registry software is primarily used by research institutions that conduct cancer research. On-premise cancer registry software offers advanced features for easy data storage such as security and easy accessibility. On-premise cancer registry software is less risky compared to other types of models. As such, on-premise cancer registry software is widely used in hospitals and research centers.

Based on the functionality the market is segmented into cancer reporting, patient care, medical research, and others. The patient care segment is expected to grow significantly during the forecast period. Patient care management is a program that includes a variety of healthcare services that help patients monitor their condition, from primary care such as scheduling appointments to short-term case management and chronic illness management. The growing number of cancer patients is attributed to the segment growth during the forecast period.

Based on end-user, the market is segmented into government, private players, hospitals, biotech pharma, and others. The government sector dominated the cancer registry software market in 2021. Governments in established and emerging countries have adopted cancer registry software on a large scale. This software helps track and monitor cancer patients in their respective regions. Added to this is government investment in implementing cancer registry software in hospitals. These factors are expected to boost of the global cancer registry software market during the forecast period.

For a better understanding of the market adoption of the cancer registry software industry, the market is analyzed based on its worldwide presence in the countries such as North America (The U.S., Canada, Rest of North America), Europe (Germany, The U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North American region is leading the cancer registry software market and is expected to maintain this during the forecast period. The presence of key market players is expected to propel the cancer registry software market in the region. Furthermore, government-funded efforts to support the development of cancer registries, and heavy investment in healthcare IT, are expected to significantly influence the market during the anticipation period. Moreover, the growing number of cancer patients in the region is also expected to drive the market during the analysis time period.

Some of the major players operating in the market include: Rocky Mountain Cancer Centers, MCKESSON CORPORATION, Netdox Health Pvt. Ltd, Elekta, IBM, C-Net Solutions, Ordinal Data Inc., Omega Healthcare, Energy & Resource Solutions, and Conduent, Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Cancer Registry Software Market
  • 2.2. Research Methodology of the Cancer Registry Software Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE CANCER REGISTRY SOFTWARE MARKET

6 CANCER REGISTRY SOFTWARE MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Standalone
  • 7.2. Integration

8 MARKET INSIGHTS BY DEPLOYMENT

  • 8.1. Cloud
  • 8.2. On-Premises

9 MARKET INSIGHTS BY FUNCTIONALITY

  • 9.1. Cancer Reporting
  • 9.2. Patient Care
  • 9.3. Medical Research
  • 9.4. Others

10 MARKET INSIGHTS BY END-USER

  • 10.1. Government
  • 10.2. Private Players
  • 10.3. Hospitals
  • 10.4. Biotech Pharma
  • 10.5. Others

11 MARKET INSIGHTS BY REGION

  • 11.1. North America
    • 11.1.1. U.S.
    • 11.1.2. Canada
    • 11.1.3. Rest of North America
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. The U.K.
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Rest of Asia-Pacific
  • 11.4. Rest of World

12 CANCER REGISTRY SOFTWARE MARKET DYNAMICS

  • 12.1. Market Drivers
  • 12.2. Market Challenges
  • 12.3. Impact Analysis

13 CANCER REGISTRY SOFTWARE MARKET OPPORTUNITIES

14 CANCER REGISTRY SOFTWARE MARKET TRENDS

15 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 15.1. Demand Side Analysis
  • 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1. Porters Five Forces Analysis

18 COMPANY PROFILED

  • 18.1. Rocky Mountain Cancer Centers
  • 18.2. MCKESSON CORPORATION
  • 18.3. Netdox Health Pvt. Ltd.
  • 18.4. Elekta
  • 18.5. IBM
  • 18.6. C-Net Solutions
  • 18.7. Ordinal Data, Inc
  • 18.8. Omega Healthcare
  • 18.9. Energy & Resource Solutions
  • 18.10. Conduent, Inc.

19 DISCLAIMER